Department of Hepatobiliary, Kyoto University, Kyoto, Japan.
Liver Transpl. 2010 Apr;16(4):453-60. doi: 10.1002/lt.22010.
Several studies have shown improved growth after liver transplantation, but long-term follow-up data have been lacking. This study was aimed at evaluating the ability of children to catch up in height after living donor liver transplantation (LDLT) and at clarifying factors affecting growth. Growth was assessed by serial height measurements performed during follow-up. Standardized height scores (z scores) were calculated for each patient preoperatively (at the baseline) and at 1, 2, 3, 5, 10, and 15 years after LDLT. The risk potential of several preoperative and postoperative variables was evaluated. A total of 237 patients, including 159 females (67.1%), met the inclusion criteria. The mean age at the time of transplant was 3.89 +/- 0.28 years. The mean z score was -1.70 +/- 0.09, whereas the baseline height deficit was -6.50 +/- 0.39 cm. After LDLT, the z score improved significantly and reached -0.64 +/- 0.14 by the end of the first year. The best height improvement was seen after 10 years (-0.33 +/- 0.16). However, significant growth retardation remained at 15 years (-0.47 +/- 0.17). Height showed 3 distinct phases after transplantation: a growth spurt, a plateau phase, and a late declining phase. Univariate and multivariate analyses showed that children under 2 years and those with the most growth retardation at the time of LDLT achieved the best height gain in the first year. Late growth retardation was related to the baseline z score, ABO-incompatible grafts, and graft dysfunction. In conclusion, children have the potential ability to catch up in growth to normal levels after LDLT; they can show impressive height gains in the first year followed by protracted improvement over 10 years and then late growth retardation. Young age is a determinant for early height gain, whereas ABO-incompatible grafts and graft dysfunction are determinants for late growth retardation. In contrast, the baseline z score is a determinant for both.
几项研究表明,肝移植后生长状况得到改善,但缺乏长期随访数据。本研究旨在评估儿童在活体肝移植(LDLT)后身高追赶的能力,并明确影响生长的因素。通过随访期间的连续身高测量评估生长情况。每位患者术前(基线时)和 LDLT 后 1、2、3、5、10 和 15 年均计算标准化身高评分(z 评分)。评估了术前和术后多个变量的风险潜力。共有 237 名患者符合纳入标准,其中 159 名女性(67.1%)。移植时的平均年龄为 3.89 ± 0.28 岁。平均 z 评分为-1.70 ± 0.09,而基线身高缺陷为-6.50 ± 0.39cm。LDLT 后,z 评分显著改善,第一年结束时达到-0.64 ± 0.14。10 年后身高改善最佳(-0.33 ± 0.16)。然而,15 年后仍存在显著生长迟缓(-0.47 ± 0.17)。移植后身高表现出 3 个明显阶段:生长突增期、平台期和晚期下降期。单因素和多因素分析表明,2 岁以下和 LDLT 时生长迟缓最严重的儿童在第一年获得最佳身高增长。晚期生长迟缓与基线 z 评分、ABO 不相容移植物和移植物功能障碍有关。总之,儿童在 LDLT 后有追赶生长至正常水平的潜力;他们可以在第一年表现出令人印象深刻的身高增长,然后在 10 年内持续改善,然后出现晚期生长迟缓。年龄较小是早期身高增长的决定因素,而 ABO 不相容移植物和移植物功能障碍是晚期生长迟缓的决定因素。相比之下,基线 z 评分是两者的决定因素。